Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · IEX Real-Time Price · USD
35.33
-0.26 (-0.73%)
At close: Apr 25, 2024, 4:00 PM
35.27
-0.06 (-0.17%)
After-hours: Apr 25, 2024, 4:58 PM EDT
Revolution Medicines Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for RVMD stock have an average target of 41.64, with a low estimate of 30 and a high estimate of 48. The average target predicts an increase of 17.86% from the current stock price of 35.33.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for RVMD stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 6 | 6 | 5 | 6 |
| Buy | 3 | 3 | 4 | 5 | 6 | 5 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 11 | 12 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $43 → $45 | Buy | Maintains | $43 → $45 | +27.37% | Apr 12, 2024 |
| Needham | Needham | Strong Buy Maintains $36 → $46 | Strong Buy | Maintains | $36 → $46 | +30.20% | Apr 12, 2024 |
| Raymond James | Raymond James | Buy → Strong Buy Upgrades $36 → $48 | Buy → Strong Buy | Upgrades | $36 → $48 | +35.86% | Apr 10, 2024 |
| Needham | Needham | Strong Buy Maintains $36 | Strong Buy | Maintains | $36 | +1.90% | Apr 8, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $43 | Buy | Initiates | $43 | +21.71% | Mar 11, 2024 |
Financial Forecast
Revenue This Year
6.76M
from 11.58M
Decreased by -41.59%
Revenue Next Year
5.66M
from 6.76M
Decreased by -16.40%
EPS This Year
-3.24
from -3.86
EPS Next Year
-3.54
from -3.24
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 38.0M | 46.2M | 73.8M | 528.2M | 877.8M |
| Avg | 6.8M | 5.7M | 21.6M | 300.4M | 594.5M |
| Low | n/a | n/a | n/a | n/a | 173.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 228.3% | 583.2% | 1,205.3% | 2,343.3% | 192.2% |
| Avg | -41.6% | -16.4% | 282.2% | 1,289.6% | 97.9% |
| Low | - | - | - | - | -42.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.14 | -2.99 | -1.41 | 0.98 | -2.59 |
| Avg | -3.24 | -3.54 | -3.38 | -1.28 | -2.52 |
| Low | -3.46 | -3.94 | -4.19 | -3.36 | -2.42 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.